Avenacy Announces Launch of Bortezomib for Injection in the U.S. Market
· financialcontent
AI Briefing
- Avenacy announces US launch of Bortezomib for Injection for multiple myeloma treatment.
- Bortezomib is approved for use in certain types of cancer and autoimmune disorders.
- Avenacy aims to improve treatment options for patients with multiple myeloma and other conditions.
Advertisement